Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins
Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for resea...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a096b460ffa43f2a9f1d30deb079393 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5a096b460ffa43f2a9f1d30deb079393 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5a096b460ffa43f2a9f1d30deb0793932021-12-02T15:08:39ZEffective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins10.1038/s41598-018-25009-32045-2322https://doaj.org/article/5a096b460ffa43f2a9f1d30deb0793932018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25009-3https://doaj.org/toc/2045-2322Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for research purposes, is impractical for adults because of the high cost of current surfactant preparations. Prior in vitro work has shown that poly-N-substituted glycines (peptoids), in a biomimetic lipid mixture, emulate key biophysical activities of lung surfactant proteins B and C at the air-water interface. Here we report good in vivo efficacy of a peptoid-based surfactant, compared with extracted animal surfactant and a synthetic lipid formulation, in a rat model of lavage-induced ALI. Adult rats were subjected to whole-lung lavage followed by administration of surfactant formulations and monitoring of outcomes. Treatment with a surfactant protein C mimic formulation improved blood oxygenation, blood pH, shunt fraction, and peak inspiratory pressure to a greater degree than surfactant protein B mimic or combined formulations. All peptoid-enhanced treatment groups showed improved outcomes compared to synthetic lipids alone, and some formulations improved outcomes to a similar extent as animal-derived surfactant. Robust biophysical mimics of natural surfactant proteins may enable new medical research in ALI treatment.Ann M. CzyzewskiLynda M. McCaigMichelle T. DohmLauren A. BroeringLi-Juan YaoNathan J. BrownMaruti K. DidwaniaJennifer S. LinJim F. LewisRuud VeldhuizenAnnelise E. BarronNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ann M. Czyzewski Lynda M. McCaig Michelle T. Dohm Lauren A. Broering Li-Juan Yao Nathan J. Brown Maruti K. Didwania Jennifer S. Lin Jim F. Lewis Ruud Veldhuizen Annelise E. Barron Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
description |
Abstract Acute lung injury (ALI) leads to progressive loss of breathing capacity and hypoxemia, as well as pulmonary surfactant dysfunction. ALI’s pathogenesis and management are complex, and it is a significant cause of morbidity and mortality worldwide. Exogenous surfactant therapy, even for research purposes, is impractical for adults because of the high cost of current surfactant preparations. Prior in vitro work has shown that poly-N-substituted glycines (peptoids), in a biomimetic lipid mixture, emulate key biophysical activities of lung surfactant proteins B and C at the air-water interface. Here we report good in vivo efficacy of a peptoid-based surfactant, compared with extracted animal surfactant and a synthetic lipid formulation, in a rat model of lavage-induced ALI. Adult rats were subjected to whole-lung lavage followed by administration of surfactant formulations and monitoring of outcomes. Treatment with a surfactant protein C mimic formulation improved blood oxygenation, blood pH, shunt fraction, and peak inspiratory pressure to a greater degree than surfactant protein B mimic or combined formulations. All peptoid-enhanced treatment groups showed improved outcomes compared to synthetic lipids alone, and some formulations improved outcomes to a similar extent as animal-derived surfactant. Robust biophysical mimics of natural surfactant proteins may enable new medical research in ALI treatment. |
format |
article |
author |
Ann M. Czyzewski Lynda M. McCaig Michelle T. Dohm Lauren A. Broering Li-Juan Yao Nathan J. Brown Maruti K. Didwania Jennifer S. Lin Jim F. Lewis Ruud Veldhuizen Annelise E. Barron |
author_facet |
Ann M. Czyzewski Lynda M. McCaig Michelle T. Dohm Lauren A. Broering Li-Juan Yao Nathan J. Brown Maruti K. Didwania Jennifer S. Lin Jim F. Lewis Ruud Veldhuizen Annelise E. Barron |
author_sort |
Ann M. Czyzewski |
title |
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
title_short |
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
title_full |
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
title_fullStr |
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
title_full_unstemmed |
Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
title_sort |
effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/5a096b460ffa43f2a9f1d30deb079393 |
work_keys_str_mv |
AT annmczyzewski effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT lyndammccaig effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT michelletdohm effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT laurenabroering effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT lijuanyao effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT nathanjbrown effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT marutikdidwania effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT jenniferslin effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT jimflewis effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT ruudveldhuizen effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins AT anneliseebarron effectiveinvivotreatmentofacutelunginjurywithhelicalamphipathicpeptoidmimicsofpulmonarysurfactantproteins |
_version_ |
1718388060516777984 |